These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31590145)

  • 21. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
    Solas M; Milagro FI; Ramírez MJ; Martínez JA
    Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
    Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain functional imaging in obese and diabetic patients.
    Guzzardi MA; Iozzo P
    Acta Diabetol; 2019 Feb; 56(2):135-144. PubMed ID: 29959509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease.
    Luo F; Rustay NR; Ebert U; Hradil VP; Cole TB; Llano DA; Mudd SR; Zhang Y; Fox GB; Day M
    Neurobiol Aging; 2012 May; 33(5):933-44. PubMed ID: 20961663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Links Between Obesity-Induced Brain Insulin Resistance, Brain Mitochondrial Dysfunction, and Dementia.
    Sripetchwandee J; Chattipakorn N; Chattipakorn SC
    Front Endocrinol (Lausanne); 2018; 9():496. PubMed ID: 30233495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional tau deposition measured by [
    Saint-Aubert L; Almkvist O; Chiotis K; Almeida R; Wall A; Nordberg A
    Alzheimers Res Ther; 2016 Sep; 8(1):38. PubMed ID: 27683159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiopharmaceuticals for Assessment of Altered Metabolism and Biometal Fluxes in Brain Aging and Alzheimer's Disease with Positron Emission Tomography.
    Xie F; Peng F
    J Alzheimers Dis; 2017; 59(2):527-536. PubMed ID: 28671127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional cerebral glucose metabolism in children with deterioration of one or more cognitive functions and continuous spike-and-wave discharges during sleep.
    Maquet P; Hirsch E; Metz-Lutz MN; Motte J; Dive D; Marescaux C; Franck G
    Brain; 1995 Dec; 118 ( Pt 6)():1497-520. PubMed ID: 8595480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between educational attainment and amyloid deposition across the spectrum from normal cognition to dementia: neuroimaging evidence for protection and compensation.
    Arenaza-Urquijo EM; Bejanin A; Gonneaud J; Wirth M; La Joie R; Mutlu J; Gaubert M; Landeau B; de la Sayette V; Eustache F; Chételat G
    Neurobiol Aging; 2017 Nov; 59():72-79. PubMed ID: 28764930
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
    Oh H; Madison C; Baker S; Rabinovici G; Jagust W
    Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of blood glucose, diabetes, insulin, and obesity on standardized uptake values in tumors and healthy organs on 18F-FDG PET/CT.
    Büsing KA; Schönberg SO; Brade J; Wasser K
    Nucl Med Biol; 2013 Feb; 40(2):206-13. PubMed ID: 23228852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences.
    Baran TM; Lin FV;
    J Alzheimers Dis; 2018; 66(1):307-318. PubMed ID: 30282358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.
    Silverman DH; Small GW; Chang CY; Lu CS; Kung De Aburto MA; Chen W; Czernin J; Rapoport SI; Pietrini P; Alexander GE; Schapiro MB; Jagust WJ; Hoffman JM; Welsh-Bohmer KA; Alavi A; Clark CM; Salmon E; de Leon MJ; Mielke R; Cummings JL; Kowell AP; Gambhir SS; Hoh CK; Phelps ME
    JAMA; 2001 Nov; 286(17):2120-7. PubMed ID: 11694153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positron emission tomography imaging of regional cerebral glucose metabolism.
    Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
    Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment.
    Grimmer T; Wutz C; Alexopoulos P; Drzezga A; Förster S; Förstl H; Goldhardt O; Ortner M; Sorg C; Kurz A
    J Nucl Med; 2016 Feb; 57(2):204-7. PubMed ID: 26585056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C
    J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.